Importantly, this loss of CD5 did not compromise the cells’ effector function, which demonstrated preserved cytotoxicity in vitro and in vivo against preclinical models of T-ALL and T cell lymphoma. Here, CD5 is linked to T-cell non-Hodgkin lymphoma.